[Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Volumn 19, Issue 11, 2011, Pages 828-832

  Xing, Jing ^a   Han, Tao ^b   Liu, Lei ^b   Li, Ying ^b   Li, Jun ^b   Li, Yan ^b   Xiao, Shi xiang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; ENTECAVIR; GUANINE; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADENINE; ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GUANINE; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; TREATMENT OUTCOME;

EID: 84864299672     PISSN: 10073418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)